#59: Could woolly mammoths walk Earth again? 🦣
This week, 10000 years after woolly mammoths went extinct, scientists are planning on bringing them back to save Asian elephants, researchers use make-up to outsmart facial recognition and how is UK-based startup Mojo tackling stigma around men’s sexual health?
News Bites 🥪
🙌 NOCD, the world’s leading provider of OCD treatment, raises $33M to address the global OCD crisis
🦣 Scientists secure $15M to resurrect woolly mammoths from extinction
💊 Mojo lands $4.4M in seed funding to transform men’s sexual health beyond pills
📱 Apple developing iPhone technology to help diagnose depression
💰 Startups founded at John Hopkins raised more than $1.2B in funding over the last fiscal year
💋 State-of-the-art facial recognition software is no match for a full face of makeup
What to Listen to 🔊
The HealthTech Podcast: The Story of Doctorpreneurs with Dr Avi Mehra
This week, James is joined by Dr Avi Mehra, a medical doctor by background, NHS Clinical Entrepreneur Programme mentor and Associate Partner for Healthcare at IBM. He is also the Co-Founder of Doctorpreneurs, a non-profit organisation and global community for medical innovators and entrepreneurs which recently celebrated 10 years…
Health Points: Gambling for Better Health & Health Gamification Research
In this episode, Pieter Van Gorp and Raoul Nuijten from Eindhoven University of Technology in the Netherlands discuss financial incentives for physical activity and how the mechanics of gambling can help to create health behaviours for lower costs…
🎉 Want to work with the latest and greatest in healthtech? Come and join us at SomX: The Healthtech Agency. We’re looking for two interns with experience/interest in graphic design, events, community management, social media, health or technology. Get in touch at email@example.com
🍐 London-based start-up, Pear Bio is hiring for several roles including Medical Director, Scientists and Developers to personalise cancer treatment for patients. Using organ-on-a-chip technology and computer vision, they are helping doctors and pharma companies to evaluate the efficacy of cancer drugs.